The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Employment - Roche/Genentech
Atezolizumab (atezo) plus platinum-based chemotherapy (chemo) in non-small cell lung cancer (NSCLC): Update from a phase Ib study.
 
Stephen V. Liu
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim; Celgene; Genentech; Lilly; Pfizer
Research Funding - Bayer; Clovis Oncology; Corvus Pharmaceuticals; Esanex; Genentech/Roche; Ignyta; MedImmune; Merck; OncoMed; Pfizer; Threshold Pharmaceuticals
 
D. Ross Camidge
No Relationships to Disclose
 
Scott N. Gettinger
No Relationships to Disclose
 
Giuseppe Giaccone
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; G1 Therapeutics; Inivata
Research Funding - AstraZeneca; Karyopharm Therapeutics; Lilly
 
Rebecca Suk Heist
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim
Research Funding - Abbvie; Celgene; Debiopharm Group; Incyte; Mirati Therapeutics; Novartis; Peregrine Pharmaceuticals; Roche; Takeda
 
F. Stephen Hodi
Employment - Dana-Farber Cancer Institute
Consulting or Advisory Role - Amgen; EMD Serono; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche
 
Neal E. Ready
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Merck
 
Wei Zhang
Employment - Roche/Genentech
 
Jeffrey Wallin
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Patents, Royalties, Other Intellectual Property - Genentech
 
Roel Funke
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Daniel Waterkamp
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Paul Foster
No Relationships to Disclose
 
Koho Iizuka
No Relationships to Disclose
 
John D. Powderly
Employment - BioCytics; Carolina BioOncology Institute
Leadership - BioCytics; Carolina BioOncology Institute
Stock and Other Ownership Interests - BioCytics; Bluebird Bio; Carolina BioOncology Institute; Juno Therapeutics; Kite, a Gilead company; Lion Biotechnologies; ZIOPHARM Oncology
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Curis; Genentech/Roche; TopAlliance BioSciences Inc
Speakers' Bureau - Bristol-Myers Squibb; Dendreon; Genentech/Roche; Merck
Research Funding - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Corvus Pharmaceuticals; Curis; EMD Serono; Genentech/Roche; Incyte; Lilly/ImClone; Macrogenics; Seagen; Top Alliance BioScience
Patents, Royalties, Other Intellectual Property - BioCytics is developing intellectual property for cellular immunotherapy